Cargando…
1901. Safety, Tolerability, and Efficacy of Fluoxetine as an Antiviral for Enterovirus D68 Associated Acute Flaccid Myelitis: A Retrospective Multicenter Cohort Study
BACKGROUND: Most patients with enterovirus (EV) D68-associated acute flaccid myelitis (AFM) have long-term disability. No effective therapies have been identified. Fluoxetine is the only FDA-approved medication with in vitro antiviral activity against EV-D68. This study retrospectively analyzed the...
Autores principales: | Messacar, Kevin, Sillau, Stefan, Hopkins, Sarah, Otten, Catherine, Wilson-Murphy, Molly, Wong, Brian, Santoro, Jonathan, Treister, Andrew, Tokhie, Harlori, Torres, Alcy, Zabrocki, Luke, Glanternik, Julia, Hurst, Amanda L, Martin, Jan, Schreiner, Teri, Makhani, Naila, DeBiasi, Roberta, Kruer, Michael, Tremoulet, Adriana H, Haren, Keith Van, Desai, Jay, Benson, Leslie, Gorman, Mark, Abzug, Mark, Tyler, Kenneth, Dominguez, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254028/ http://dx.doi.org/10.1093/ofid/ofy210.1557 |
Ejemplares similares
-
1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018
por: Messacar, Kevin, et al.
Publicado: (2019) -
Notes from the Field: Cluster of Acute Flaccid Myelitis in Five Pediatric Patients — Maricopa County, Arizona, 2016
por: Iverson, Sally A., et al.
Publicado: (2017) -
Acute Flaccid Myelitis
por: Zappa, Dane, et al.
Publicado: (2022) -
Epidemiological dynamics of enterovirus D68 in the US: implications for acute flaccid myelitis
por: Park, Sang Woo, et al.
Publicado: (2021) -
170. Acute Flaccid Myelitis: Patient Characteristics and Prospective Follow-up Study at Children’s National Hospital, 2013–2019
por: Yonts, Alexandra B, et al.
Publicado: (2020)